Navamedic ASA (OSL:NAVA)

Norway flag Norway · Delayed Price · Currency is NOK
21.60
-0.10 (-0.46%)
At close: Dec 5, 2025
-11.84%
Market Cap 518.00M
Revenue (ttm) 539.42M
Net Income (ttm) -37.89M
Shares Out 23.98M
EPS (ttm) n/a
PE Ratio n/a
Forward PE 18.19
Dividend n/a
Ex-Dividend Date n/a
Volume 9,528
Average Volume 6,511
Open 22.10
Previous Close 21.70
Day's Range 21.00 - 22.10
52-Week Range 17.10 - 28.40
Beta 0.19
RSI 49.88
Earnings Date Apr 29, 2026

About Navamedic ASA

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company’s product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic and propioni... [Read more]

Sector Healthcare
Founded 2002
Employees 42
Stock Exchange Oslo Børs
Ticker Symbol NAVA
Full Company Profile

Financial Performance

In 2024, Navamedic ASA's revenue was 531.44 million, an increase of 3.80% compared to the previous year's 512.00 million. Losses were -5.49 million, -59.92% less than in 2023.

Financial Statements

News

There is no news available yet.